Dr Meredith Giblin
I have a BSC in Biochemistry and Biophysics from Rensselaer Polytechnic Institute in New York. I completed my PhD in Cell and Developmental Biology at Vanderbilt University in 2021. My PhD research was focused on understanding the role of cytokine-induced ECM alterations in diabetic retinopathy pathology. I joined the group in 2022 and will be working to characterize the transcriptome of rTEM neutrophils.